AstraZeneca Wins Funding In England For First & Second Line Leukemia Drug
Calquence Will Provide A Chemo-Free Treatment Option for CLL
Executive Summary
Health technology assessment body NICE believes that Calquence may be better tolerated and cause fewer side effects than existing treatments.